321 related articles for article (PubMed ID: 24350616)
1. High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines.
Grover A; Troudt J; Foster C; Basaraba R; Izzo A
Immunology; 2014 May; 142(1):111-23. PubMed ID: 24350616
[TBL] [Abstract][Full Text] [Related]
2. Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis.
Kebriaei A; Derakhshan M; Meshkat Z; Eidgahi MR; Rezaee SA; Farsiani H; Mosavat A; Soleimanpour S; Ghazvini K
Mol Biol Rep; 2016 Sep; 43(9):911-22. PubMed ID: 27251218
[TBL] [Abstract][Full Text] [Related]
3. Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv.
Fatma F; Tripathi DK; Srivastava M; Srivastava KK; Arora A
Tuberculosis (Edinb); 2021 Mar; 127():102054. PubMed ID: 33550109
[TBL] [Abstract][Full Text] [Related]
4. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
[TBL] [Abstract][Full Text] [Related]
5. Immunological characteristics of Mycobacterium tuberculosis subunit vaccines immunized through different routes.
Lu Y; Kang J; Ning H; Wang L; Xu Y; Xue Y; Xu Z; Wu X; Bai Y
Microb Pathog; 2018 Dec; 125():84-92. PubMed ID: 30195646
[TBL] [Abstract][Full Text] [Related]
6. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens.
Derrick SC; Yabe IM; Yang A; Kolibab K; Hollingsworth B; Kurtz SL; Morris S
Vaccine; 2013 Sep; 31(41):4641-6. PubMed ID: 23906890
[TBL] [Abstract][Full Text] [Related]
8. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
[TBL] [Abstract][Full Text] [Related]
9. A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice.
Liu X; Da Z; Wang Y; Niu H; Li R; Yu H; He S; Guo M; Wang Y; Luo Y; Ma X; Zhu B
Vaccine; 2016 Mar; 34(11):1370-8. PubMed ID: 26845736
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.
Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212
[TBL] [Abstract][Full Text] [Related]
11. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL
Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059
[TBL] [Abstract][Full Text] [Related]
12. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
Wang QM; Kang L; Wang XH
Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397
[TBL] [Abstract][Full Text] [Related]
13. Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice.
Choi HG; Choi S; Back YW; Paik S; Park HS; Kim WS; Kim H; Cha SB; Choi CH; Shin SJ; Kim HJ
Oncotarget; 2017 Mar; 8(12):19947-19967. PubMed ID: 28193909
[TBL] [Abstract][Full Text] [Related]
14. Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection.
Wang C; Lu J; Du W; Wang G; Li X; Shen X; Su C; Yang L; Chen B; Wang J; Xu M
Vaccine; 2019 Jul; 37(32):4477-4484. PubMed ID: 31266673
[TBL] [Abstract][Full Text] [Related]
15. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
16. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
Xu J; Xu W; Chen X; Zhao D; Wang Y
Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
[TBL] [Abstract][Full Text] [Related]
17. In vivo electroporation of a codon-optimized BER
Tang J; Cai Y; Liang J; Tan Z; Tang X; Zhang C; Cheng L; Zhou J; Wang H; Yam WC; Chen X; Wang H; Chen Z
Tuberculosis (Edinb); 2018 Dec; 113():65-75. PubMed ID: 30514515
[TBL] [Abstract][Full Text] [Related]
18. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
[TBL] [Abstract][Full Text] [Related]
19. Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6:CFP-10 complex.
Farsiani H; Mosavat A; Soleimanpour S; Sadeghian H; Akbari Eydgahi MR; Ghazvini K; Sankian M; Aryan E; Jamehdar SA; Rezaee SA
Mol Biosyst; 2016 Jun; 12(7):2189-201. PubMed ID: 27138226
[TBL] [Abstract][Full Text] [Related]
20. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
Villarreal DO; Siefert RJ; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
